ArticleArchives of medical sciences. Atherosclerotic diseases2026
Planned first-line bilateral femoral access for endovascular treatment of unilateral common iliac artery chronic total occlusion: procedural control and outcomes.
Article in Archives of medical sciences. Atherosclerotic diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic total occlusion (CTO) of the common iliac artery (CIA) represents a technically challenging subset of aorto-iliac occlusive disease, particularly when the lesion extends close to the aorto-iliac bifurcation. Although endovascular therapy has become the preferred treatment modality, the optimal access strategy for unilateral CIA CTO remains uncertain. This study aimed to evaluate the feasibility, procedural control, and clinical outcomes of a planned first-line bilateral femoral access strategy in unilateral CIA CTO. Material and methods: This retrospective single-centre study included 30 consecutive patients with unilateral CIA CTO who underwent endovascular revascularisation using a first-line bilateral femoral approach between January 2020 and December 2024. Continuous contralateral diagnostic angiography was used to guide the lesion crossing and stent deployment. Lesions were classified according to the TransAtlantic Inter-Society Consensus (TASC II). Technical success was defined as residual stenosis < 30% with restoration of antegrade flow. Procedural complications and mid-term clinical outcomes were assessed. Results: Most lesions were classified as TASC II C-D (86.7%). Technical success was achieved in 93.3% of cases. Periprocedural complications were infrequent and included access-site haematoma (6.7%), flow-limiting dissection (3.3%), and distal embolisation (3.3%). During a median follow-up of 13 months, symptom recurrence occurred in 20.0% of patients. Imaging performed in symptomatic patients confirmed restenosis or reocclusion in 13.3%, and target lesion revascularisation was required in 10.0% of cases. Conclusions: A planned first-line bilateral femoral endovascular approach for unilateral CIA CTO is feasible and safe, achieving high technical success with low complication rates even in predominantly TASC II C-D lesions. By enhancing procedural control and bifurcation preservation, this strategy may be particularly valuable in anatomically complex cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.